Oral Session
Wed. May 31, 2023 3:35 PM - 5:05 PM Room14 (東京ベイ幕張ホール 2F No.９,10)
Chair:Fujihara Kazuo (Department of Multiple Sclerosis Therapeutics, Fukushima Medical University, Japan)
Juichi Fujimori, Ichiro Nakashima (Division of Neurology, Tohoku Medical and Pharmaceutical University, Japan)
Schedule
Like
)
Masami Tanaka1,2 (1.Kyoto Min-Iren Chuo Hospital, Japan, 2.Kaikoukai Josai Hospital, Japan)
Schedule
Like
)
Hayato So1, Yuko Shimizu1,2, Ryotaro Ikeguchi1, Akihiro Kondo1, Kazuo Kitagawa1 (1.Department of Neurology, Tokyo Women's Medical University Hospital, Japan, 2.Department of Medical Safety, Tokyo Women's Medical University Hospital, Japan)
Schedule
Like
)
Kenzo Sakurai, Kenji Isahaya, Takeshi Imai, Naoki Takao, Yoshihisa Yamano (Department of Neurology, St. Marianna University School of Medicine, Japan)
Schedule
Like
)
Hiroyuki Toda1, Toyokazu Saiki2, Jun-ichi Kira3,4 (1.Novartis Pharma K.K. Medical Affairs Division, Japan, 2.Mitsubishi Tanabe Pharma Corporation, Japan, 3.International University of Health and Welfare, Japan, 4.Brain and Nerve Center, Fukuoka Central Hospital, Japan)
Schedule
Like
)
Kazuo Fujihara1, Kyouko Okumura2, Hideaki Hida2, Saori Yamauchi2, Satoshi Yuki2, Shinya Hirota2, Yoshito Nagano2 (1.Department of Multiple Sclerosis Therapeutics, Fukushima Medical University, Japan, 2.Mitsubishi Tanabe Pharma Corporation, Japan)
Schedule
Like
)